Biocredit VITROS SARS CoV2 Antigen CLIA based Examine

Description

Lateral motion immunochromatographic assay that adopted twin color system.
For the qualitative detection of SARS-CoV-2 antigen from nasopharyngeal swab specimen.
The verify incorporates colloid gold conjugate pad and a membrane strip pre-coated with antibodies specific to SARS-CoV-2 antigen on the verify traces (T).
A visible black band (antibody-antigen-antibody gold conjugate sophisticated) appears on the verify traces (T) If SARS-CoV-2 antigen is present throughout the specimen.
The administration line (C) reveals that verify is carried out appropriately.
Evaluated with panel specimen (n = 75) by PCR
Sensitivity: 90,2 %
Specificity: 100 %

Diagnostics

1. The VITROS SARS CoV2 Antigen assay is a chemiluminescent immunoassay meant for the qualitative
detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal (NP) specimens from individuals who
are suspected of COVID-19 inside one to five days of the onset of indicators, or mid-turbinate specimens
collected from asymptomatic individuals.
2. The assay must be carried out in VITROS 3600 Immunodiagnostics system or VITROS 5600 / VITROS XT 7600
Constructed-in system from Ortho.

Features

COVID-19, Nasopharyngeal swabs

 

SKU:G61RHA20

AVAILABILITY:In Stock with The Lowest Value throughout the Market

SHIPMENT:Related Day Cargo Orders Sooner than 14

H00SIZE:20 Exams/KitSPECIFICITY:98.90%

Type

Immunochromatography speedy verify

Biocredit Antigen Test
Biocredit Antigen Test

Guidance for use of VITROS SARS CoV2 Antigen CLIA based Examine from Ortho Medical

Calibration Differ

Qualitative

VITROS SARS CoV2 antigen assay – Procedural Steps: –

Stage 1: Nasopharyngeal swab specimen assortment:
1. Purchase a nasopharyngeal swab specimen by inserting the sterile swab into the nostril.
2. Push the sterile swab until resistance is met on the stage of the turbinate.
3. Rotate the sterile swab plenty of events in direction of the nasopharyngeal wall & go away throughout the place for
10 seconds to saturate the swab tip.
4. Take away the swab from the nostril fastidiously.
5. Place the swab specimen into the viral transport medium buffer tube and shut the tube tightly.
6. Transport the swab sample in VTM to the laboratory in a cold chain.
7. The sample may very well be saved in Room temperature (Beneath 30◦C) for as a lot as 24 hrs from the time of
sample assortment or at 2 – 8◦C for as a lot as 48 hrs from the time of sample assortment.

Stage 2: Sample preparation for testing:

1. Sample preparation should be carried out in BSL-2 stage cabinet throughout the Laboratory.
2. Mix the swab specimen in VTM tube properly (vortex roughly 3-5 seconds).
3. Change 100 μL VITROS SARS-CoV-2 Antigen Extraction Buffer proper right into a labelled new sample tube.
4. Add 400 μL viral sample to the above tube (to deal with 1:4 ratio of extraction buffer: sample)
5. Mix properly (Cap/Plug the sample tube and vortex roughly 3-5 seconds).

Panbio COVID-19 AG RAPID T Device 25T NP

41FK10 25 Tests/Kit
EUR 220

Panbio COVID-19 AG RAPID T DEVICE 25T NS

41FK11 25 Tests/Kit
EUR 123.75
Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19

COVID-19 + Influenza A. B Ag Rapid Test, Cs

R0188C 1fi Ask for price

COVID-19 Ag Detection Kit (Colloidal Gold Immunochromatography)

MBS398097-20Tests 20Tests
EUR 325

Truenat™ COVID-19

601430005 5T
EUR 60

Truenat™ COVID-19

601430020 20T
EUR 240

Truenat™ COVID-19

601430050 50T
EUR 600

COVID-19 variant pack

SB072 0.5
EUR 2325.81
Description: SARS-CoV-2 Spike (S) glycoprotein:Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein in a class I fusion protein that allows the virus to enter host cells.Variants package available:Some proteins of Sars-CoV-2 are identified as leading targets for COVID-19 therapies. SB-PEPTIDE offers a special pack pre-made peptide libraries of Spike protein including peptides from COVID-19 variants: UK COVID-19 variant B.1.1.7, South Africa COVID-19 variant B.1.351, Brazil COVID-19 variant B.1.1.248. SB-PEPTIDE offers additional plate containing only peptides with Spike S protein mutation of COVID-19 B.1.1.7, B.1.3.5.1 and B.1.1.248 (cited below).Variants package and Spike (S) glycoprotein peptide library can be used for T-cell assays, immune monitoring, antigen specific T-cell stimulation, T-cell expansion and cellular immune response.

COVID-19 Spike Antigen

30-2018 1 mg
EUR 400
Description: COVID-19 Spike recombinant antigen

COVID-19 Spike Antigen

30-2019 1 mg
EUR 400
Description: COVID-19 Spike recombinant antigen

Moderna COVID-19 Vaccine

H7N7-319 1 vial
EUR 798.4
Description: Protein

SARS & COVID-19 coronavirus

3862 each
EUR 330
Description: nucleoprotein

SARS & COVID-19 coronavirus

3863 each
EUR 330
Description: nucleoprotein

SARS & COVID-19 coronavirus

3864 each
EUR 330
Description: nucleoprotein

COVID-19 Negative Control

MBS412771-05mL 0.5mL
EUR 100

COVID-19 Negative Control

MBS412771-5x05mL 5x0.5mL
EUR 305

COVID-19 Nucleocapsid protein

30-2005 1 mg
EUR 700
Description: COVID-19 Nucleocapsid protein recombinant antigen

COVID-19 Nucleocapsid protein

30-2006 1 mg
EUR 700
Description: COVID-19 Nucleocapsid protein recombinant Antigen

COVID-19 Nucleocapsid antigen

30-2020 1 mg
EUR 400
Description: COVID-19 Nucleocapsid recombinant protein

COVID-19 Nucleocapsid antigen

30-2021 1 mg
EUR 400
Description: COVID-19 Nucleocapsid recombinant protein

Coronavirus (COVID-19) Antibody

MBS569951-1mg 1mg
EUR 655

Coronavirus (COVID-19) Antibody

MBS569951-5x1mg 5x1mg
EUR 2760

COVID-19 Nucleocapsid Protein

MBS669369-005mg 0.05mg
EUR 500

COVID-19 Nucleocapsid Protein

MBS669369-025mg 0.25mg
EUR 1010

COVID-19 Nucleocapsid Protein

MBS669369-5x025mg 5x0.25mg
EUR 4525

COVID-19 Nucleoprotein antibody

10-2890 1 mg
EUR 420
Description: Purified COVID-19 Nucleoprotein Antibody

COVID-19 Nucleoprotein antibody

10-2891 1 mg
EUR 420
Description: Purified COVID-19 Nucleoprotein Antibody

COVID-19 Nucleoprotein antibody

10-2894 1 mg
EUR 420
Description: Purified COVID-19 Nucleoprotein Antibody

COVID-19 Nucleoprotein antibody

MBS5316694-1mg 1mg
EUR 360

COVID-19 Nucleoprotein antibody

MBS5316694-5x1mg 5x1mg
EUR 1480

COVID-19 Nucleoprotein antibody

MBS5316695-1mg 1mg
EUR 360

COVID-19 Nucleoprotein antibody

MBS5316695-5x1mg 5x1mg
EUR 1480

Covid 19 spike RBD

MBS596204-1mg 1mg
EUR 425

Covid 19 spike RBD

MBS596204-2mg 2mg
EUR 700

Covid 19 spike RBD

MBS596204-5mg 5mg
EUR 1505

Coronavirus COVID-19 Spike (COVID-19, SARS-CoV-2, 2019-nCoV) ELISA Kit

MBS7612502-10x96StripWells 10x96-Strip-Wells
EUR 3900

Leave a Comment